Under pressure on performance, fujian cosunter pharmaceutical's controlling shareholder introduced strategic investors through an agreement transfer. The latest announcement of the company shows that the controlling shareholder fujian Aohua Group Co., Ltd. (hereinafter referred to as 'Aohua Group') transferred its 5.02% stake in the company to Zhangzhou Yuanshan Health Industry Investment Fund Partnership (Limited Partnership) (hereinafter referred to as 'Yuanshan Fund'). It is worth noting that the Yuanshan Fund has a strong backing, with partners including state-owned wholly-owned companies, zhangzhou pientzehuang pharmaceutical wholly-owned subsidiaries, among which the subsidiary under zhangzhou pientzehuang is the largest limited partner in terms of contribution proportion. (Beijing Business Daily)